Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Depigoid Grass Mix in patients with al-lergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.

Trial Profile

Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Depigoid Grass Mix in patients with al-lergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jul 2011

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Allergic asthma; Allergic rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top